Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in
Home>News>This Article

Vitamin D Could Provide New and Effective Treatments for Asthma

Published: Monday, May 20, 2013
Last Updated: Monday, May 20, 2013
Bookmark and Share
Vitamin D has the potential to significantly reduce the symptoms of asthma, according to a new study from the Medical Research Council (MRC).

The study, led by Professor Catherine Hawrylowicz is published today in the Journal of Allergy and Clinical Immunology and highlights Vitamin D as a possible new treatment for the condition.

Asthma can be a debilitating condition and affects 5.4 million people in the UK alone, costing the NHS approximately £1 billion each year. Severe asthma is currently treated with steroid tablets which can have harmful side effects. Many sufferers have a steroid resistant variation of the condition making it even more difficult to treat and resulting in frequent admissions to hospital with severe, even life-threatening, asthma attacks.

In a study funded by Asthma UK, a team of scientists at King’s, as part of King’s Health Partners Academic Health Sciences Centre, identified a mechanism through which Vitamin D can reduce asthma symptoms, providing a potential target for future treatments.

IL-17A is a natural chemical which helps to defend the body against infection, but is known to exacerbate asthma and reduce responsiveness to steroids when produced in larger amounts. The team examined the production of IL-17A and levels of the chemical in cells from 18 steroid resistant asthma patients and 10 patients who responded to steroids, from Guy’s and St Thomas’ NHS Foundation Trust, as well as a control group of 10 healthy participants.

Results showed that patients with asthma had much higher levels of IL-17A than those without asthma and patients with steroid resistant asthma expressed the highest levels of IL-17A.

Further observation showed that while steroids were unable to lower the production of IL-17A in cells from patients with asthma, Vitamin D significantly reduced the production of IL-17A in cells from all patients studied. The results therefore demonstrate that Vitamin D could potentially provide an effective add-on treatment for all asthma sufferers, reducing the amount of steroid-based medicines prescribed.

Professor Hawrylowicz from the MRC-Asthma UK Centre at King’s said:

“These findings are very exciting as they show that Vitamin D could one day be used not only to treat people with steroid resistant asthma but also to reduce the doses of steroids in other asthma patients, reducing the risk of harmful side effects. The results are so positive that we are testing this in a clinical trial in steroid resistant asthma patients to further research the possibilities of Vitamin D as a potential treatment.”

Malayka Rahman, Research Analysis and Communications Officer at Asthma UK, said:

“For the majority of people with asthma, current available medicines are an effective way of managing the condition but we know that they don't work for everyone, which is why research into new treatments is vital. We also know that many people with asthma have concerns about the side effects of their medicines so if vitamin D is shown to reduce the amount of medicines required, this would have an enormous impact on people's quality of life. We look forward to the results of the clinical trial.”

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,600+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Making Vaccines More Effective In The Elderly
Compound shown to restore the immune system’s inbuilt memory.
Tuesday, November 11, 2014
Immune Organ Regenerated in Mice
Scientists have for the first time used regenerative medicine to fully restore a degenerated organ in a living animal.
Tuesday, April 08, 2014
New Type of Blood Stem Cell Could Help Solve Platelet Shortage
Scientists have identified a new type of bone marrow stem cell in mice that is primed to produce large numbers of vital blood-clotting platelets.
Tuesday, August 13, 2013
Scientific News
3 Ways Viruses Have Changed Science for the Better
Viruses are really good at what they do, and we’ve been able to harness their skills to learn about – and potentially improve – human health in several ways.
Mixed Up Cell Transportation Key Piece of ALS and Dementia Puzzle
Researchers from the University of Toronto are one step closer to solving this incredibly complex puzzle, offering hope for treatment.
Antibody Treatment Efficacious in Psoriasis
An experimental, biologic treatment, brodalumab, achieved 100 percent reduction in psoriasis symptoms in twice as many patients as a second, commonly used treatment, according to the results of a multicenter clinical trial led by Mount Sinai researchers.
Four Gut Bacteria Decrease Asthma Risk in Infants
New research by scientists at UBC and BC Children’s Hospital finds that infants can be protected from getting asthma if they acquire four types of gut bacteria by three months of age.
Escape Prevention
Studying flu virus structure brings us a step closer to a permanent vaccine.
New Molecular Marker for Killer Cells
Cell marker enables prognosis about the course of infections.
Editing Genes to Create HIV Killers
Seattle scientists have managed to genetically transform human cells in the lab from HIV targets to HIV killers, and the technique could have implications for cancer and other diseases.
Antibiotic Overuse Might be Why so Many People Have Allergies
The Centers for Disease Control and Prevention estimates that drug resistant bacteria cause 23,000 deaths and two million illnesses each year.
Molecular ‘Kiss Of Death’ Flags Pathogens For Destruction
Researchers have discovered that our bodies mark pathogen-containing vacuoles for destruction by using a molecule called ubiquitin, commonly known as the "kiss of death."
Opening the Door to Safer, More Precise Cancer Therapies
New method regulates when, and how strongly, cancer-killing therapeutic T cells are activated.

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos